Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 62

1.

Neuronal Enriched Extracellular Vesicle Proteins as Biomarkers for Brain Traumatic Injury.

Karnati HK, Garcia JH, Tweedie D, Becker RE, Kapogiannis D, Greig NH.

J Neurotrauma. 2018 Jul 24. doi: 10.1089/neu.2018.5898. [Epub ahead of print]

PMID:
30039737
2.

Beneficial effect of minimal interference on item memory but not on source memory in Alzheimer's disease.

Kapogiannis D, El Haj M.

Curr Alzheimer Res. 2018 Jul 10. doi: 10.2174/1567205015666180711105242. [Epub ahead of print]

PMID:
29992879
3.

Deficient neurotrophic factors of CSPG4-type neural cell exosomes in Alzheimer disease.

Goetzl EJ, Nogueras-Ortiz C, Mustapic M, Mullins RJ, Abner EL, Schwartz JB, Kapogiannis D.

FASEB J. 2018 Jun 20:fj201801001. doi: 10.1096/fj.201801001. [Epub ahead of print]

PMID:
29924942
4.

Higher exosomal tau, amyloid-beta 42 and IL-10 are associated with mild TBIs and chronic symptoms in military personnel.

Gill J, Mustapic M, Diaz-Arrastia R, Lange R, Gulyani S, Diehl T, Motamedi V, Osier N, Stern RA, Kapogiannis D.

Brain Inj. 2018;32(10):1277-1284. doi: 10.1080/02699052.2018.1471738. Epub 2018 Jun 18.

PMID:
29913077
5.

Effect of intermittent vs. daily calorie restriction on changes in weight and patient-reported outcomes in people with multiple sclerosis.

Fitzgerald KC, Vizthum D, Henry-Barron B, Schweitzer A, Cassard SD, Kossoff E, Hartman AL, Kapogiannis D, Sullivan P, Baer DJ, Mattson MP, Appel LJ, Mowry EM.

Mult Scler Relat Disord. 2018 Jul;23:33-39. doi: 10.1016/j.msard.2018.05.002. Epub 2018 May 5.

PMID:
29753994
6.

Effects of creatine supplementation on cognitive function of healthy individuals: A systematic review of randomized controlled trials.

Avgerinos KI, Spyrou N, Bougioukas KI, Kapogiannis D.

Exp Gerontol. 2018 Jul 15;108:166-173. doi: 10.1016/j.exger.2018.04.013. Epub 2018 Apr 25. Review.

PMID:
29704637
7.

Magnetic resonance spectroscopy reveals abnormalities of glucose metabolism in the Alzheimer's brain.

Mullins R, Reiter D, Kapogiannis D.

Ann Clin Transl Neurol. 2018 Jan 29;5(3):262-272. doi: 10.1002/acn3.530. eCollection 2018 Mar.

8.

Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles.

Guix FX, Corbett GT, Cha DJ, Mustapic M, Liu W, Mengel D, Chen Z, Aikawa E, Young-Pearse T, Kapogiannis D, Selkoe DJ, Walsh DM.

Int J Mol Sci. 2018 Feb 27;19(3). pii: E663. doi: 10.3390/ijms19030663.

9.

High complement levels in astrocyte-derived exosomes of Alzheimer disease.

Goetzl EJ, Schwartz JB, Abner EL, Jicha GA, Kapogiannis D.

Ann Neurol. 2018 Mar;83(3):544-552. doi: 10.1002/ana.25172. Epub 2018 Mar 10.

PMID:
29406582
10.

(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.

Becker RE, Greig NH, Lahiri DK, Bledsoe J, Majercik S, Ballard C, Aarsland D, Schneider LS, Flanagan D, Govindarajan R, Sano M, Ferrucci L, Kapogiannis D.

Curr Alzheimer Res. 2018;15(9):883-891. doi: 10.2174/1567205015666180110120026.

11.

Does traumatic brain injury hold the key to the Alzheimer's disease puzzle?

Becker RE, Kapogiannis D, Greig NH.

Alzheimers Dement. 2018 Apr;14(4):431-443. doi: 10.1016/j.jalz.2017.11.007. Epub 2017 Dec 12.

PMID:
29245000
12.

Negative Prospective Memory in Alzheimer's Disease: "Do Not Perform That Action".

El Haj M, Coello Y, Kapogiannis D, Gallouj K, Antoine P.

J Alzheimers Dis. 2018;61(2):663-672. doi: 10.3233/JAD-170807.

PMID:
29226877
13.

Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.

Lewczuk P, Riederer P, O'Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lleó A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, Van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J; Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut.

World J Biol Psychiatry. 2018 Jun;19(4):244-328. doi: 10.1080/15622975.2017.1375556. Epub 2017 Oct 27.

PMID:
29076399
14.

From Nose to Memory: The Involuntary Nature of Odor-evoked Autobiographical Memories in Alzheimer's Disease.

El Haj M, Gandolphe MC, Gallouj K, Kapogiannis D, Antoine P.

Chem Senses. 2017 Dec 25;43(1):27-34. doi: 10.1093/chemse/bjx064.

PMID:
29040475
15.

Declining levels of functionally specialized synaptic proteins in plasma neuronal exosomes with progression of Alzheimer's disease.

Goetzl EJ, Abner EL, Jicha GA, Kapogiannis D, Schwartz JB.

FASEB J. 2018 Feb;32(2):888-893. doi: 10.1096/fj.201700731R. Epub 2018 Jan 4.

PMID:
29025866
16.

In a randomized trial in prostate cancer patients, dietary protein restriction modifies markers of leptin and insulin signaling in plasma extracellular vesicles.

Eitan E, Tosti V, Suire CN, Cava E, Berkowitz S, Bertozzi B, Raefsky SM, Veronese N, Spangler R, Spelta F, Mustapic M, Kapogiannis D, Mattson MP, Fontana L.

Aging Cell. 2017 Dec;16(6):1430-1433. doi: 10.1111/acel.12657. Epub 2017 Sep 17.

17.

Walking speed decline in older adults is associated with elevated pro-BDNF in plasma extracellular vesicles.

Suire CN, Eitan E, Shaffer NC, Tian Q, Studenski S, Mattson MP, Kapogiannis D.

Exp Gerontol. 2017 Nov;98:209-216. doi: 10.1016/j.exger.2017.08.024. Epub 2017 Aug 23.

PMID:
28843509
18.

Time distortions in Alzheimer's disease: a systematic review and theoretical integration.

El Haj M, Kapogiannis D.

NPJ Aging Mech Dis. 2016 Sep 8;2:16016. doi: 10.1038/npjamd.2016.16. eCollection 2016. Review.

19.

Plasma Extracellular Vesicles Enriched for Neuronal Origin: A Potential Window into Brain Pathologic Processes.

Mustapic M, Eitan E, Werner JK Jr, Berkowitz ST, Lazaropoulos MP, Tran J, Goetzl EJ, Kapogiannis D.

Front Neurosci. 2017 May 22;11:278. doi: 10.3389/fnins.2017.00278. eCollection 2017.

20.

Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease.

Mullins RJ, Diehl TC, Chia CW, Kapogiannis D.

Front Aging Neurosci. 2017 May 3;9:118. doi: 10.3389/fnagi.2017.00118. eCollection 2017.

21.

Insulin resistance and exendin-4 treatment for multiple system atrophy.

Bassil F, Canron MH, Vital A, Bezard E, Li Y, Greig NH, Gulyani S, Kapogiannis D, Fernagut PO, Meissner WG.

Brain. 2017 May 1;140(5):1420-1436. doi: 10.1093/brain/awx044.

PMID:
28334990
22.

Clinical and neurocognitive aspects of hallucinations in Alzheimer's disease.

El Haj M, Roche J, Jardri R, Kapogiannis D, Gallouj K, Antoine P.

Neurosci Biobehav Rev. 2017 Dec;83:713-720. doi: 10.1016/j.neubiorev.2017.02.021. Epub 2017 Feb 21. Review.

PMID:
28235545
23.

RNA in extracellular vesicles.

Kim KM, Abdelmohsen K, Mustapic M, Kapogiannis D, Gorospe M.

Wiley Interdiscip Rev RNA. 2017 Jul;8(4). doi: 10.1002/wrna.1413. Epub 2017 Jan 28. Review.

24.

Exosomal biomarkers of brain insulin resistance associated with regional atrophy in Alzheimer's disease.

Mullins RJ, Mustapic M, Goetzl EJ, Kapogiannis D.

Hum Brain Mapp. 2017 Apr;38(4):1933-1940. doi: 10.1002/hbm.23494. Epub 2017 Jan 20.

25.

Insulin resistance in Alzheimer's disease.

Diehl T, Mullins R, Kapogiannis D.

Transl Res. 2017 May;183:26-40. doi: 10.1016/j.trsl.2016.12.005. Epub 2016 Dec 13. Review.

26.

Extracellular Vesicle-Associated Aβ Mediates Trans-Neuronal Bioenergetic and Ca2+-Handling Deficits in Alzheimer's Disease Models.

Eitan E, Hutchison ER, Marosi K, Comotto J, Mustapic M, Nigam SM, Suire C, Maharana C, Jicha GA, Liu D, Machairaki V, Witwer KW, Kapogiannis D, Mattson MP.

NPJ Aging Mech Dis. 2016;2. pii: 16019. Epub 2016 Sep 22.

27.

Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.

Goetzl EJ, Mustapic M, Kapogiannis D, Eitan E, Lobach IV, Goetzl L, Schwartz JB, Miller BL.

FASEB J. 2016 Nov;30(11):3853-3859. Epub 2016 Aug 10.

28.

Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease.

Goetzl EJ, Kapogiannis D, Schwartz JB, Lobach IV, Goetzl L, Abner EL, Jicha GA, Karydas AM, Boxer A, Miller BL.

FASEB J. 2016 Dec;30(12):4141-4148. Epub 2016 Sep 6.

29.

Phenomenological Reliving and Visual Imagery During Autobiographical Recall in Alzheimer's Disease.

El Haj M, Kapogiannis D, Antoine P.

J Alzheimers Dis. 2016 Mar 16;52(2):421-31. doi: 10.3233/JAD-151122.

30.

Apolipoprotein E (APOE) ε4 and episodic memory decline in Alzheimer's disease: A review.

El Haj M, Antoine P, Amouyel P, Lambert JC, Pasquier F, Kapogiannis D.

Ageing Res Rev. 2016 May;27:15-22. doi: 10.1016/j.arr.2016.02.002. Epub 2016 Feb 11. Review.

31.

Low neural exosomal levels of cellular survival factors in Alzheimer's disease.

Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Carlson OD, Mustapic M, Kapogiannis D.

Ann Clin Transl Neurol. 2015 Jul;2(7):769-73. doi: 10.1002/acn3.211. Epub 2015 May 13.

32.

Autobiographical memory decline in Alzheimer's disease, a theoretical and clinical overview.

El Haj M, Antoine P, Nandrino JL, Kapogiannis D.

Ageing Res Rev. 2015 Sep;23(Pt B):183-92. doi: 10.1016/j.arr.2015.07.001. Epub 2015 Jul 10. Review.

33.

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease.

Goetzl EJ, Boxer A, Schwartz JB, Abner EL, Petersen RC, Miller BL, Kapogiannis D.

Neurology. 2015 Jul 7;85(1):40-7. doi: 10.1212/WNL.0000000000001702. Epub 2015 Jun 10.

34.

Flexibility decline contributes to similarity of past and future thinking in Alzheimer's disease.

El Haj M, Antoine P, Kapogiannis D.

Hippocampus. 2015 Nov;25(11):1447-55. doi: 10.1002/hipo.22465. Epub 2015 Apr 18.

35.

Energy metabolism and the brain: a bidirectional relationship.

Kapogiannis D.

Ageing Res Rev. 2015 Mar;20:35-6. doi: 10.1016/j.arr.2015.02.002. No abstract available.

36.

Insulin resistance predicts medial temporal hypermetabolism in mild cognitive impairment conversion to Alzheimer disease.

Willette AA, Modanlo N, Kapogiannis D; Alzheimer’s Disease Neuroimaging Initiative.

Diabetes. 2015 Jun;64(6):1933-40. doi: 10.2337/db14-1507. Epub 2015 Jan 9.

37.

Similarity between remembering the past and imagining the future in Alzheimer's disease: Implication of episodic memory.

El Haj M, Antoine P, Kapogiannis D.

Neuropsychologia. 2015 Jan;66:119-25. doi: 10.1016/j.neuropsychologia.2014.11.015. Epub 2014 Nov 20.

38.

Dysfunctionally phosphorylated type 1 insulin receptor substrate in neural-derived blood exosomes of preclinical Alzheimer's disease.

Kapogiannis D, Boxer A, Schwartz JB, Abner EL, Biragyn A, Masharani U, Frassetto L, Petersen RC, Miller BL, Goetzl EJ.

FASEB J. 2015 Feb;29(2):589-96. doi: 10.1096/fj.14-262048. Epub 2014 Oct 23.

39.

Prognostic classification of mild cognitive impairment and Alzheimer's disease: MRI independent component analysis.

Willette AA, Calhoun VD, Egan JM, Kapogiannis D; Alzheimer׳s Disease Neuroimaging Initiative.

Psychiatry Res. 2014 Nov 30;224(2):81-8. doi: 10.1016/j.pscychresns.2014.08.005. Epub 2014 Aug 17.

40.

Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study.

Fiandaca MS, Kapogiannis D, Mapstone M, Boxer A, Eitan E, Schwartz JB, Abner EL, Petersen RC, Federoff HJ, Miller BL, Goetzl EJ.

Alzheimers Dement. 2015 Jun;11(6):600-7.e1. doi: 10.1016/j.jalz.2014.06.008. Epub 2014 Aug 15.

41.

Frontotemporal dementia and its subtypes: a genome-wide association study.

Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P.

Lancet Neurol. 2014 Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1.

42.

Does the brain shrink as the waist expands?

Willette AA, Kapogiannis D.

Ageing Res Rev. 2015 Mar;20:86-97. doi: 10.1016/j.arr.2014.03.007. Epub 2014 Apr 22. Review.

43.

Brain networks shaping religious belief.

Kapogiannis D, Deshpande G, Krueger F, Thornburg MP, Grafman JH.

Brain Connect. 2014 Feb;4(1):70-9. doi: 10.1089/brain.2013.0172. Epub 2014 Jan 15.

44.

Aging enhances release of exosomal cytokine mRNAs by Aβ1-42-stimulated macrophages.

Mitsuhashi M, Taub DD, Kapogiannis D, Eitan E, Zukley L, Mattson MP, Ferrucci L, Schwartz JB, Goetzl EJ.

FASEB J. 2013 Dec;27(12):5141-50. doi: 10.1096/fj.13-238980. Epub 2013 Sep 6.

45.

Posteromedial cortex glutamate and GABA predict intrinsic functional connectivity of the default mode network.

Kapogiannis D, Reiter DA, Willette AA, Mattson MP.

Neuroimage. 2013 Jan 1;64:112-9. doi: 10.1016/j.neuroimage.2012.09.029. Epub 2012 Sep 18.

46.

The five factors of personality and regional cortical variability in the Baltimore longitudinal study of aging.

Kapogiannis D, Sutin A, Davatzikos C, Costa P Jr, Resnick S.

Hum Brain Mapp. 2013 Nov;34(11):2829-40. doi: 10.1002/hbm.22108. Epub 2012 May 19.

47.

Screening for C9ORF72 repeat expansion in FTLD.

Ferrari R, Mok K, Moreno JH, Cosentino S, Goldman J, Pietrini P, Mayeux R, Tierney MC, Kapogiannis D, Jicha GA, Murrell JR, Ghetti B, Wassermann EM, Grafman J, Hardy J, Huey ED, Momeni P.

Neurobiol Aging. 2012 Aug;33(8):1850.e1-11. doi: 10.1016/j.neurobiolaging.2012.02.017. Epub 2012 Mar 27.

48.

Alcohol consumption and premotor corpus callosum in older adults.

Kapogiannis D, Kisser J, Davatzikos C, Ferrucci L, Metter J, Resnick SM.

Eur Neuropsychopharmacol. 2012 Oct;22(10):704-10. doi: 10.1016/j.euroneuro.2012.02.003. Epub 2012 Mar 6.

49.

Towards segmentation of the thymus in fat and water parametric MR images.

Makrogiannis S, Ramachandran R, Fishbein KW, Kapogiannis D, Spencer RG, Chia CW.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:8078-81. doi: 10.1109/IEMBS.2011.6091992.

50.

Reward processing abnormalities in Parkinson's disease.

Kapogiannis D, Mooshagian E, Campion P, Grafman J, Zimmermann TJ, Ladt KC, Wassermann EM.

Mov Disord. 2011 Jul;26(8):1451-7. doi: 10.1002/mds.23701. Epub 2011 Apr 29.

Supplemental Content

Loading ...
Support Center